Summary
Hepatitis B vaccine is a vaccine that prevents hepatitis B.
According to APO Research, The global Hepatitis B Vaccines market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Hepatitis B Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Hepatitis B Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Hepatitis B Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Hepatitis B Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, KM Biologics, LG Life Sciences and Serum Institute, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Hepatitis B Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Hepatitis B Vaccines, also provides the sales of main regions and countries. Of the upcoming market potential for Hepatitis B Vaccines, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Hepatitis B Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Hepatitis B Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Hepatitis B Vaccines sales, projected growth trends, production technology, application and end-user industry.
Hepatitis B Vaccines segment by Company
GSK
NCPC
Merck
Bio Kangtai
Dynavax
Hissen
KM Biologics
LG Life Sciences
Serum Institute
Hepatitis B Vaccines segment by Type
Yeast Derived
CHO Derived
Hepatitis B Vaccines segment by Application
Children
Adult
Hepatitis B Vaccines segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Hepatitis B Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hepatitis B Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Hepatitis B Vaccines Market by Type
1.2.1 Global Hepatitis B Vaccines Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Yeast Derived
1.2.3 CHO Derived
1.3 Hepatitis B Vaccines Market by Application
1.3.1 Global Hepatitis B Vaccines Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Children
1.3.3 Adult
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Hepatitis B Vaccines Market Dynamics
2.1 Hepatitis B Vaccines Industry Trends
2.2 Hepatitis B Vaccines Industry Drivers
2.3 Hepatitis B Vaccines Industry Opportunities and Challenges
2.4 Hepatitis B Vaccines Industry Restraints
3 Global Market Growth Prospects
3.1 Global Hepatitis B Vaccines Revenue Estimates and Forecasts (2019-2030)
3.2 Global Hepatitis B Vaccines Revenue by Region
3.2.1 Global Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Hepatitis B Vaccines Revenue by Region (2019-2024)
3.2.3 Global Hepatitis B Vaccines Revenue by Region (2025-2030)
3.2.4 Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
3.3 Global Hepatitis B Vaccines Sales Estimates and Forecasts 2019-2030
3.4 Global Hepatitis B Vaccines Sales by Region
3.4.1 Global Hepatitis B Vaccines Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Hepatitis B Vaccines Sales by Region (2019-2024)
3.4.3 Global Hepatitis B Vaccines Sales by Region (2025-2030)
3.4.4 Global Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 Market Competitive Landscape by Manufacturers
4.1 Global Hepatitis B Vaccines Revenue by Manufacturers
4.1.1 Global Hepatitis B Vaccines Revenue by Manufacturers (2019-2024)
4.1.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Hepatitis B Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Hepatitis B Vaccines Sales by Manufacturers
4.2.1 Global Hepatitis B Vaccines Sales by Manufacturers (2019-2024)
4.2.2 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Hepatitis B Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Hepatitis B Vaccines Sales Price by Manufacturers (2019-2024)
4.4 Global Hepatitis B Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Hepatitis B Vaccines Manufacturers, Product Type & Application
4.7 Global Hepatitis B Vaccines Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Hepatitis B Vaccines Market CR5 and HHI
4.8.2 2023 Hepatitis B Vaccines Tier 1, Tier 2, and Tier 3
5 Hepatitis B Vaccines Market by Type
5.1 Global Hepatitis B Vaccines Revenue by Type
5.1.1 Global Hepatitis B Vaccines Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Hepatitis B Vaccines Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030)
5.2 Global Hepatitis B Vaccines Sales by Type
5.2.1 Global Hepatitis B Vaccines Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Hepatitis B Vaccines Sales by Type (2019-2030) & (M Doses)
5.2.3 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030)
5.3 Global Hepatitis B Vaccines Price by Type
6 Hepatitis B Vaccines Market by Application
6.1 Global Hepatitis B Vaccines Revenue by Application
6.1.1 Global Hepatitis B Vaccines Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Hepatitis B Vaccines Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030)
6.2 Global Hepatitis B Vaccines Sales by Application
6.2.1 Global Hepatitis B Vaccines Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Hepatitis B Vaccines Sales by Application (2019-2030) & (M Doses)
6.2.3 Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030)
6.3 Global Hepatitis B Vaccines Price by Application
7 Company Profiles
7.1 GSK
7.1.1 GSK Comapny Information
7.1.2 GSK Business Overview
7.1.3 GSK Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 GSK Hepatitis B Vaccines Product Portfolio
7.1.5 GSK Recent Developments
7.2 NCPC
7.2.1 NCPC Comapny Information
7.2.2 NCPC Business Overview
7.2.3 NCPC Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 NCPC Hepatitis B Vaccines Product Portfolio
7.2.5 NCPC Recent Developments
7.3 Merck
7.3.1 Merck Comapny Information
7.3.2 Merck Business Overview
7.3.3 Merck Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Merck Hepatitis B Vaccines Product Portfolio
7.3.5 Merck Recent Developments
7.4 Bio Kangtai
7.4.1 Bio Kangtai Comapny Information
7.4.2 Bio Kangtai Business Overview
7.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
7.4.5 Bio Kangtai Recent Developments
7.5 Dynavax
7.5.1 Dynavax Comapny Information
7.5.2 Dynavax Business Overview
7.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
7.5.5 Dynavax Recent Developments
7.6 Hissen
7.6.1 Hissen Comapny Information
7.6.2 Hissen Business Overview
7.6.3 Hissen Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Hissen Hepatitis B Vaccines Product Portfolio
7.6.5 Hissen Recent Developments
7.7 KM Biologics
7.7.1 KM Biologics Comapny Information
7.7.2 KM Biologics Business Overview
7.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
7.7.5 KM Biologics Recent Developments
7.8 LG Life Sciences
7.8.1 LG Life Sciences Comapny Information
7.8.2 LG Life Sciences Business Overview
7.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
7.8.5 LG Life Sciences Recent Developments
7.9 Serum Institute
7.9.1 Serum Institute Comapny Information
7.9.2 Serum Institute Business Overview
7.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
7.9.5 Serum Institute Recent Developments
8 North America
8.1 North America Hepatitis B Vaccines Market Size by Type
8.1.1 North America Hepatitis B Vaccines Revenue by Type (2019-2030)
8.1.2 North America Hepatitis B Vaccines Sales by Type (2019-2030)
8.1.3 North America Hepatitis B Vaccines Price by Type (2019-2030)
8.2 North America Hepatitis B Vaccines Market Size by Application
8.2.1 North America Hepatitis B Vaccines Revenue by Application (2019-2030)
8.2.2 North America Hepatitis B Vaccines Sales by Application (2019-2030)
8.2.3 North America Hepatitis B Vaccines Price by Application (2019-2030)
8.3 North America Hepatitis B Vaccines Market Size by Country
8.3.1 North America Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Hepatitis B Vaccines Price by Country (2019-2030)
8.3.4 United States
8.3.5 Canada
9 Europe
9.1 Europe Hepatitis B Vaccines Market Size by Type
9.1.1 Europe Hepatitis B Vaccines Revenue by Type (2019-2030)
9.1.2 Europe Hepatitis B Vaccines Sales by Type (2019-2030)
9.1.3 Europe Hepatitis B Vaccines Price by Type (2019-2030)
9.2 Europe Hepatitis B Vaccines Market Size by Application
9.2.1 Europe Hepatitis B Vaccines Revenue by Application (2019-2030)
9.2.2 Europe Hepatitis B Vaccines Sales by Application (2019-2030)
9.2.3 Europe Hepatitis B Vaccines Price by Application (2019-2030)
9.3 Europe Hepatitis B Vaccines Market Size by Country
9.3.1 Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Hepatitis B Vaccines Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 China
10.1 China Hepatitis B Vaccines Market Size by Type
10.1.1 China Hepatitis B Vaccines Revenue by Type (2019-2030)
10.1.2 China Hepatitis B Vaccines Sales by Type (2019-2030)
10.1.3 China Hepatitis B Vaccines Price by Type (2019-2030)
10.2 China Hepatitis B Vaccines Market Size by Application
10.2.1 China Hepatitis B Vaccines Revenue by Application (2019-2030)
10.2.2 China Hepatitis B Vaccines Sales by Application (2019-2030)
10.2.3 China Hepatitis B Vaccines Price by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Hepatitis B Vaccines Market Size by Type
11.1.1 Asia Hepatitis B Vaccines Revenue by Type (2019-2030)
11.1.2 Asia Hepatitis B Vaccines Sales by Type (2019-2030)
11.1.3 Asia Hepatitis B Vaccines Price by Type (2019-2030)
11.2 Asia Hepatitis B Vaccines Market Size by Application
11.2.1 Asia Hepatitis B Vaccines Revenue by Application (2019-2030)
11.2.2 Asia Hepatitis B Vaccines Sales by Application (2019-2030)
11.2.3 Asia Hepatitis B Vaccines Price by Application (2019-2030)
11.3 Asia Hepatitis B Vaccines Market Size by Country
11.3.1 Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Hepatitis B Vaccines Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 Middle East, Africa and Latin America
12.1 MEALA Hepatitis B Vaccines Market Size by Type
12.1.1 MEALA Hepatitis B Vaccines Revenue by Type (2019-2030)
12.1.2 MEALA Hepatitis B Vaccines Sales by Type (2019-2030)
12.1.3 MEALA Hepatitis B Vaccines Price by Type (2019-2030)
12.2 MEALA Hepatitis B Vaccines Market Size by Application
12.2.1 MEALA Hepatitis B Vaccines Revenue by Application (2019-2030)
12.2.2 MEALA Hepatitis B Vaccines Sales by Application (2019-2030)
12.2.3 MEALA Hepatitis B Vaccines Price by Application (2019-2030)
12.3 MEALA Hepatitis B Vaccines Market Size by Country
12.3.1 MEALA Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Hepatitis B Vaccines Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 Value Chain and Sales Channels Analysis
13.1 Hepatitis B Vaccines Value Chain Analysis
13.1.1 Hepatitis B Vaccines Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Hepatitis B Vaccines Production Mode & Process
13.2 Hepatitis B Vaccines Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Hepatitis B Vaccines Distributors
13.2.3 Hepatitis B Vaccines Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
List of Tables
Table 1. Global Hepatitis B Vaccines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 2. Yeast Derived Major Manufacturers
Table 3. CHO Derived Major Manufacturers
Table 4. Global Hepatitis B Vaccines Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Children Major Manufacturers
Table 6. Adult Major Manufacturers
Table 7. Hepatitis B Vaccines Industry Trends
Table 8. Hepatitis B Vaccines Industry Drivers
Table 9. Hepatitis B Vaccines Industry Opportunities and Challenges
Table 10. Hepatitis B Vaccines Industry Restraints
Table 11. Global Hepatitis B Vaccines Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 12. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 13. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 14. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024)
Table 15. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030)
Table 16. Global Hepatitis B Vaccines Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Table 17. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
Table 18. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
Table 19. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis B Vaccines Revenue by Manufacturers (US$ Million) & (2019-2024)
Table 22. Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
Table 23. Global Hepatitis B Vaccines Sales by Manufacturers (US$ Million) & (2019-2024)
Table 24. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 25. Global Hepatitis B Vaccines Sales Price (USD/Doses) of Manufacturers (2019-2024)
Table 26. Global Hepatitis B Vaccines Key Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 27. Global Hepatitis B Vaccines Key Manufacturers Manufacturing Sites & Headquarters
Table 28. Global Hepatitis B Vaccines Manufacturers, Product Type & Application
Table 29. Global Hepatitis B Vaccines Manufacturers Commercialization Time
Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Hepatitis B Vaccines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 32. Global Hepatitis B Vaccines Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 33. Global Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 34. Global Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 35. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024)
Table 36. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030)
Table 37. Global Hepatitis B Vaccines Sales by Type 2019 VS 2023 VS 2030 (M Doses)
Table 38. Global Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 39. Global Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 40. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
Table 41. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030)
Table 42. Global Hepatitis B Vaccines Price by Type (2019-2024) & (USD/Doses)
Table 43. Global Hepatitis B Vaccines Price by Type (2025-2030) & (USD/Doses)
Table 44. Global Hepatitis B Vaccines Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 45. Global Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 46. Global Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 47. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024)
Table 48. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030)
Table 49. Global Hepatitis B Vaccines Sales by Application 2019 VS 2023 VS 2030 (M Doses)
Table 50. Global Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 51. Global Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 52. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
Table 53. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030)
Table 54. Global Hepatitis B Vaccines Price by Application (2019-2024) & (USD/Doses)
Table 55. Global Hepatitis B Vaccines Price by Application (2025-2030) & (USD/Doses)
Table 56. GSK Company Information
Table 57. GSK Business Overview
Table 58. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 59. GSK Hepatitis B Vaccines Product Portfolio
Table 60. GSK Recent Development
Table 61. NCPC Company Information
Table 62. NCPC Business Overview
Table 63. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 64. NCPC Hepatitis B Vaccines Product Portfolio
Table 65. NCPC Recent Development
Table 66. Merck Company Information
Table 67. Merck Business Overview
Table 68. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 69. Merck Hepatitis B Vaccines Product Portfolio
Table 70. Merck Recent Development
Table 71. Bio Kangtai Company Information
Table 72. Bio Kangtai Business Overview
Table 73. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 74. Bio Kangtai Hepatitis B Vaccines Product Portfolio
Table 75. Bio Kangtai Recent Development
Table 76. Dynavax Company Information
Table 77. Dynavax Business Overview
Table 78. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 79. Dynavax Hepatitis B Vaccines Product Portfolio
Table 80. Dynavax Recent Development
Table 81. Hissen Company Information
Table 82. Hissen Business Overview
Table 83. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 84. Hissen Hepatitis B Vaccines Product Portfolio
Table 85. Hissen Recent Development
Table 86. KM Biologics Company Information
Table 87. KM Biologics Business Overview
Table 88. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 89. KM Biologics Hepatitis B Vaccines Product Portfolio
Table 90. KM Biologics Recent Development
Table 91. LG Life Sciences Company Information
Table 92. LG Life Sciences Business Overview
Table 93. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 94. LG Life Sciences Hepatitis B Vaccines Product Portfolio
Table 95. LG Life Sciences Recent Development
Table 96. Serum Institute Company Information
Table 97. Serum Institute Business Overview
Table 98. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 99. Serum Institute Hepatitis B Vaccines Product Portfolio
Table 100. Serum Institute Recent Development
Table 101. North America Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 102. North America Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 103. North America Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 104. North America Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 105. North America Hepatitis B Vaccines Sales Price by Type (2019-2024) & (USD/Doses)
Table 106. North America Hepatitis B Vaccines Sales Price by Type (2025-2030) & (USD/Doses)
Table 107. North America Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 108. North America Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 109. North America Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 110. North America Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 111. North America Hepatitis B Vaccines Sales Price by Application (2019-2024) & (USD/Doses)
Table 112. North America Hepatitis B Vaccines Sales Price by Application (2025-2030) & (USD/Doses)
Table 113. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 115. North America Hepatitis B Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 116. North America Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 117. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 118. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 119. North America Hepatitis B Vaccines Sales Price by Country (2019-2024) & (USD/Doses)
Table 120. North America Hepatitis B Vaccines Sales Price by Country (2025-2030) & (USD/Doses)
Table 121. US Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 122. Canada Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 123. Europe Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 124. Europe Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 125. Europe Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 126. Europe Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 127. Europe Hepatitis B Vaccines Sales Price by Type (2019-2024) & (USD/Doses)
Table 128. Europe Hepatitis B Vaccines Sales Price by Type (2025-2030) & (USD/Doses)
Table 129. Europe Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 130. Europe Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 131. Europe Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 132. Europe Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 133. Europe Hepatitis B Vaccines Sales Price by Application (2019-2024) & (USD/Doses)
Table 134. Europe Hepatitis B Vaccines Sales Price by Application (2025-2030) & (USD/Doses)
Table 135. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 136. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 137. Europe Hepatitis B Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 138. Europe Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 139. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 140. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 141. Europe Hepatitis B Vaccines Sales Price by Country (2019-2024) & (USD/Doses)
Table 142. Europe Hepatitis B Vaccines Sales Price by Country (2025-2030) & (USD/Doses)
Table 143. Germany Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 144. France Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 145. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 146. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 147. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 148. China Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 149. China Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 150. China Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 151. China Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 152. China Hepatitis B Vaccines Sales Price by Type (2019-2024) & (USD/Doses)
Table 153. China Hepatitis B Vaccines Sales Price by Type (2025-2030) & (USD/Doses)
Table 154. China Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 155. China Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 156. China Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 157. China Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 158. China Hepatitis B Vaccines Sales Price by Application (2019-2024) & (USD/Doses)
Table 159. China Hepatitis B Vaccines Sales Price by Application (2025-2030) & (USD/Doses)
Table 160. Asia Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 161. Asia Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 162. Asia Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 163. Asia Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 164. Asia Hepatitis B Vaccines Sales Price by Type (2019-2024) & (USD/Doses)
Table 165. Asia Hepatitis B Vaccines Sales Price by Type (2025-2030) & (USD/Doses)
Table 166. Asia Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 167. Asia Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 168. Asia Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 169. Asia Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 170. Asia Hepatitis B Vaccines Sales Price by Application (2019-2024) & (USD/Doses)
Table 171. Asia Hepatitis B Vaccines Sales Price by Application (2025-2030) & (USD/Doses)
Table 172. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 173. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 174. Asia Hepatitis B Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 175. Asia Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 176. Asia Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 177. Asia Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 178. Asia Hepatitis B Vaccines Sales Price by Country (2019-2024) & (USD/Doses)
Table 179. Asia Hepatitis B Vaccines Sales Price by Country (2025-2030) & (USD/Doses)
Table 180. Japan Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 181. South Korea Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 182. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 183. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 184. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 185. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 186. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 187. Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 188. MEALA Hepatitis B Vaccines Revenue by Type (2019-2024) & (US$ Million)
Table 189. MEALA Hepatitis B Vaccines Revenue by Type (2025-2030) & (US$ Million)
Table 190. MEALA Hepatitis B Vaccines Sales by Type (2019-2024) & (M Doses)
Table 191. MEALA Hepatitis B Vaccines Sales by Type (2025-2030) & (M Doses)
Table 192. MEALA Hepatitis B Vaccines Sales Price by Type (2019-2024) & (USD/Doses)
Table 193. MEALA Hepatitis B Vaccines Sales Price by Type (2025-2030) & (USD/Doses)
Table 194. MEALA Hepatitis B Vaccines Revenue by Application (2019-2024) & (US$ Million)
Table 195. MEALA Hepatitis B Vaccines Revenue by Application (2025-2030) & (US$ Million)
Table 196. MEALA Hepatitis B Vaccines Sales by Application (2019-2024) & (M Doses)
Table 197. MEALA Hepatitis B Vaccines Sales by Application (2025-2030) & (M Doses)
Table 198. MEALA Hepatitis B Vaccines Sales Price by Application (2019-2024) & (USD/Doses)
Table 199. MEALA Hepatitis B Vaccines Sales Price by Application (2025-2030) & (USD/Doses)
Table 200. MEALA Hepatitis B Vaccines Revenue Grow Rate by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 201. MEALA Hepatitis B Vaccines Revenue Grow Rate by Country (2019-2024) & (US$ Million)
Table 202. MEALA Hepatitis B Vaccines Revenue Grow Rate by Country (2025-2030) & (US$ Million)
Table 203. MEALA Hepatitis B Vaccines Sales by Country (2019 VS 2023 VS 2030) & (M Doses)
Table 204. MEALA Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 205. MEALA Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 206. MEALA Hepatitis B Vaccines Sales Price by Country (2019-2024) & (USD/Doses)
Table 207. MEALA Hepatitis B Vaccines Sales Price by Country (2025-2030) & (USD/Doses)
Table 208. Mexico Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 209. Brazil Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 210. Israel Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 211. Argentina Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 212. Colombia Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 213. Turkey Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 214. Saudi Arabia Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 215. UAE Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Table 216. Key Raw Materials
Table 217. Raw Materials Key Suppliers
Table 218. Hepatitis B Vaccines Distributors List
Table 219. Hepatitis B Vaccines Customers List
Table 220. Research Programs/Design for This Report
Table 221. Authors List of This Report
Table 222. Secondary Sources
Table 223. Primary Sources
List of Figures
Figure 1. Hepatitis B Vaccines Product Picture
Figure 2. Global Hepatitis B Vaccines Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Hepatitis B Vaccines Market Size Share 2019 VS 2023 VS 2030
Figure 4. Yeast Derived Picture
Figure 5. CHO Derived Picture
Figure 6. Global Hepatitis B Vaccines Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Hepatitis B Vaccines Market Size Share 2019 VS 2023 VS 2030
Figure 8. Children Picture
Figure 9. Adult Picture
Figure 10. Global Hepatitis B Vaccines Revenue (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Hepatitis B Vaccines Revenue (2019-2030) & (US$ Million)
Figure 12. Global Hepatitis B Vaccines Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 13. Global Hepatitis B Vaccines Revenue Market Share by Region: 2023 Versus 2030
Figure 14. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
Figure 15. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses)
Figure 16. Global Hepatitis B Vaccines Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (M Doses)
Figure 17. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
Figure 18. US & Canada Hepatitis B Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 19. Europe Hepatitis B Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 20. China Hepatitis B Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 21. Asia (Excluding China) Hepatitis B Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 22. Middle East, Africa and Latin America (Excluding China) Hepatitis B Vaccines Sales YoY (2019-2030) & (M Doses)
Figure 23. Global Hepatitis B Vaccines Manufacturers Revenue Share Top 10 and Top 5 in 2023
Figure 24. Global Hepatitis B Vaccines Manufacturers Sales Share Top 10 and Top 5 in 2023
Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 26. Global Hepatitis B Vaccines Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Hepatitis B Vaccines Revenue Market Share by Type 2019 VS 2023 VS 2030
Figure 28. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030)
Figure 29. Global Hepatitis B Vaccines Sales by Type (2019 VS 2023 VS 2030) & (M Doses)
Figure 30. Global Hepatitis B Vaccines Sales Market Share by Type 2019 VS 2023 VS 2030
Figure 31. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030)
Figure 32. Global Hepatitis B Vaccines Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 33. Global Hepatitis B Vaccines Revenue Market Share by Application 2019 VS 2023 VS 2030
Figure 34. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030)
Figure 35. Global Hepatitis B Vaccines Sales by Application (2019 VS 2023 VS 2030) & (M Doses)
Figure 36. Global Hepatitis B Vaccines Sales Market Share by Application 2019 VS 2023 VS 2030
Figure 37. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030)
Figure 38. North America Hepatitis B Vaccines Revenue Share by Type (2019-2030)
Figure 39. North America Hepatitis B Vaccines Sales Share by Type (2019-2030)
Figure 40. North America Hepatitis B Vaccines Revenue Share by Application (2019-2030)
Figure 41. North America Hepatitis B Vaccines Sales Share by Application (2019-2030)
Figure 42. North America Hepatitis B Vaccines Revenue Share by Country (2019-2030)
Figure 43. North America Hepatitis B Vaccines Sales Share by Country (2019-2030)
Figure 44. Europe Hepatitis B Vaccines Revenue Share by Type (2019-2030)
Figure 45. Europe Hepatitis B Vaccines Sales Share by Type (2019-2030)
Figure 46. Europe Hepatitis B Vaccines Revenue Share by Application (2019-2030)
Figure 47. Europe Hepatitis B Vaccines Sales Share by Application (2019-2030)
Figure 48. Europe Hepatitis B Vaccines Revenue Share by Country (2019-2030)
Figure 49. Europe Hepatitis B Vaccines Sales Share by Country (2019-2030)
Figure 50. China Hepatitis B Vaccines Revenue Share by Type (2019-2030)
Figure 51. China Hepatitis B Vaccines Sales Share by Type (2019-2030)
Figure 52. China Hepatitis B Vaccines Revenue Share by Application (2019-2030)
Figure 53. China Hepatitis B Vaccines Sales Share by Application (2019-2030)
Figure 54. Asia Hepatitis B Vaccines Revenue Share by Type (2019-2030)
Figure 55. Asia Hepatitis B Vaccines Sales Share by Type (2019-2030)
Figure 56. Asia Hepatitis B Vaccines Revenue Share by Application (2019-2030)
Figure 57. Asia Hepatitis B Vaccines Sales Share by Application (2019-2030)
Figure 58. Asia Hepatitis B Vaccines Revenue Share by Country (2019-2030)
Figure 59. Asia Hepatitis B Vaccines Sales Share by Country (2019-2030)
Figure 60. MEALA Hepatitis B Vaccines Revenue Share by Type (2019-2030)
Figure 61. MEALA Hepatitis B Vaccines Sales Share by Type (2019-2030)
Figure 62. MEALA Hepatitis B Vaccines Revenue Share by Application (2019-2030)
Figure 63. MEALA Hepatitis B Vaccines Sales Share by Application (2019-2030)
Figure 64. MEALA Hepatitis B Vaccines Revenue Share by Country (2019-2030)
Figure 65. MEALA Hepatitis B Vaccines Sales Share by Country (2019-2030)
Figure 66. Hepatitis B Vaccines Value Chain
Figure 67. Manufacturing Cost Structure
Figure 68. Hepatitis B Vaccines Production Mode & Process
Figure 69. Direct Comparison with Distribution Share
Figure 70. Distributors Profiles
Figure 71. Years Considered
Figure 72. Research Process
Figure 73. Key Executives Interviewed
